litlas
ログインアカウント作成

Daniel Wojdyla

2004–2026 年に発表

115
論文数
22,931
被引用数
68
h 指数
100
i10 指数

被引用数

Daniel Wojdyla の年別被引用数2003 年: 被引用 2 件2004 年: 被引用 1 件2005 年: 被引用 3 件2006 年: 被引用 18 件2007 年: 被引用 44 件2008 年: 被引用 53 件2009 年: 被引用 60 件2010 年: 被引用 106 件2011 年: 被引用 154 件2012 年: 被引用 154 件2013 年: 被引用 218 件2014 年: 被引用 221 件2015 年: 被引用 207 件2016 年: 被引用 179 件2017 年: 被引用 199 件2018 年: 被引用 163 件2019 年: 被引用 578 件2020 年: 被引用 655 件2021 年: 被引用 581 件2022 年: 被引用 405 件2023 年: 被引用 306 件2024 年: 被引用 510 件2025 年: 被引用 253 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,805 件、この内訳の 18.1%イギリス: 引用元論文 889 件、この内訳の 8.9%カナダ: 引用元論文 501 件、この内訳の 5%イタリア: 引用元論文 490 件、この内訳の 4.9%中国: 引用元論文 430 件、この内訳の 4.3%ドイツ: 引用元論文 389 件、この内訳の 3.9%オランダ: 引用元論文 338 件、この内訳の 3.4%オーストラリア: 引用元論文 335 件、この内訳の 3.4%フランス: 引用元論文 304 件、この内訳の 3.1%スイス: 引用元論文 283 件、この内訳の 2.8%スウェーデン: 引用元論文 273 件、この内訳の 2.7%スペイン: 引用元論文 227 件、この内訳の 2.3%
0%18.1%その他 37.2%

機関

分野

  • Medicine88.1%
  • Nursing2.3%
  • Biochemistry, Genetics and Molecular Biology2.2%
  • Health Professions1.4%
  • Environmental Science1%
  • Agricultural and Biological Sciences0.9%
  • その他4.1%

トピック

  • Atrial Fibrillation Management and Outcomes6.3%
  • Pregnancy and preeclampsia studies4.9%
  • Antiplatelet Therapy and Cardiovascular Diseases3.4%
  • Maternal and fetal healthcare3.4%
  • Global Maternal and Child Health3.3%
  • Iron Metabolism and Disorders3.2%
  • その他75.5%

共著者

全論文

検索で開く
  1. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005

    著者: Erin McLean, Mary E. Cogswell, Ines Egli, Daniel Wojdyla, Bruno de Benoist - Public Health Nutrition 2008 被引用: 2,744

  2. WHO analysis of causes of maternal death: a systematic review

    著者: Khalid S. Khan, Daniel Wojdyla, Lale Say, A. Metin Gülmezog̈lu, Paul FA Van Look - The Lancet 2006 被引用: 4,027

  3. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

    著者: Anthony P. Carnicelli, Hwanhee Hong, Stuart J. Connolly, John Eikelboom, Robert P. Giugliano, David A. Morrow, Manesh R. Patel, Lars Wallentin, John H. Alexander, M. Cecilia Bahit, Alexander P. Benz, Erin A. Bohula, Tze-Fan Chao, Leanne Dyal, Michael Ezekowitz, Keith A.A. Fox, Baris Gencer, Jonathan L. Halperin, Ziad Hijazi, Stefan H. Hohnloser, Kaiyuan Hua, Elaine Hylek, Eri Toda Kato, Julia Kuder, Renato D. Lopes, Kenneth W. Mahaffey, Jonas Oldgren, Jonathan P. Piccini, Christian T. Ruff, Jan Steffel, Daniel Wojdyla, Christopher B. Granger - Circulation 2022 被引用: 369

  4. Quantifying Importance of Major Risk Factors for Coronary Heart Disease

    著者: Michael Pencina, Ann Marie Návar, Daniel Wojdyla, Robert J. Sanchez, Irfan Khan, Joseph Elassal, Ralph B. D’Agostino, Eric D. Peterson, Allan D. Sniderman - Circulation 2019 被引用: 245

  5. Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups

    著者: Chuan Hong, Michael Pencina, Daniel Wojdyla, Jennifer L. Hall, Suzanne E. Judd, Michael P. Cary, Matthew Engelhard, Samuel I. Berchuck, Ying Xian, Ralph B. D’Agostino, George Howard, Brett Kissela, Ricardo Henao - JAMA 2023 被引用: 94

  6. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity

    著者: Stacey Beck, Daniel Wojdyla, Lale Say, Ana Pilar Bertran, Mario Meraldi, Jennifer Requejo, Craig E. Rubens, Ramkumar Menon, Paul Van Look - Bulletin of the World Health Organization 2009 被引用: 2,151

  7. Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up

    著者: Mario Gaudino, Sigrid Sandner, Kevin R. An, Arnaldo Dimagli, Antonino Di Franco, Katia Audisio, Lamia Harik, Roberto Perezgrovas‐Olaria, Giovanni Soletti, Stephen E. Fremes, David L. Hare, Alexander Kulik, André Lamy, Joyce Peper, Marc Ruel, Jurriën M. ten Berg, Laura M. Willemsen, Qiang Zhao, Daniel Wojdyla, Deepak L. Bhatt, John H. Alexander, Björn Redfors - Circulation 2023 被引用: 101

  8. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

    著者: John W. Stanifer, Sean D. Pokorney, Glenn M. Chertow, Stefan H. Hohnloser, Daniel Wojdyla, Samira M. Garonzik, Wonkyung Byon, Ziad Hijazi, Renato D. Lópes, John H. Alexander, Lars Wallentin, Christopher B. Granger - Circulation 2020 被引用: 164

  9. The association between triglycerides and incident cardiovascular disease: What is “optimal”?

    著者: Tsion Aberra, Eric D. Peterson, Neha J. Pagidipati, Hillary Mulder, Daniel Wojdyla, Sephy Philip, Craig Granowitz, Ann Marie Návar - Journal of clinical lipidology 2020 被引用: 119

  10. Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation

    著者: Renato D. Lópes, Christopher B. Granger, Daniel Wojdyla, William F. McIntyre, Marco Alings, Thenmozhi Mani, Chinthanie Ramasundarahettige, Léna Rivard, Dan Atar, David H. Birnie, Giuseppe Boriani, Guy Amit, Peter Leong‐Sit, Claus Rinne, Gábor Zoltán Duray, Michael R. Gold, Stefan H. Hohnloser, Valentina Kutyifa, Juan Benezet‐Mazuecos, Jens Cosedis Nielsen, Christian Sticherling, Alexander P. Benz, Cecilia Linde, J Kautzner, Philippe Mabo, Georges H. Mairesse, Stuart J. Connolly, Jeff S. Healey - Journal of the American College of Cardiology 2024 被引用: 69

  11. Digoxin and Mortality in Patients With Atrial Fibrillation

    著者: Renato D. Lópes, Roberto Rordorf, Gaetano Maria De Ferrari, Sergio Leonardi, Laine Thomas, Daniel Wojdyla, Peter Ridefelt, John H. Lawrence, Raffaele De Caterina, Dragoş Vinereanu, Michael Hanna, Greg Flaker, Sana M. Al‐Khatib, Stefan H. Hohnloser, John H. Alexander, Christopher B. Granger, Lars Wallentin - Journal of the American College of Cardiology 2018 被引用: 213

  12. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention

    著者: John H. Alexander, Daniel Wojdyla, Amit N. Vora, Laine Thomas, Christopher B. Granger, Shaun G. Goodman, Ronald Aronson, Stephan Windecker, Roxana Mehran, Renato D. Lópes - Circulation 2020 被引用: 130

  13. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

    著者: Keith A.A. Fox, Jonathan P. Piccini, Daniel Wojdyla, Richard C. Becker, Jonathan L. Halperin, Christopher C. Nessel, John F. Paolini, Graeme J. Hankey, Kenneth W. Mahaffey, Manesh R. Patel, Daniel E. Singer, Robert M. Califf - European Heart Journal 2011 被引用: 614

  14. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

    著者: José Villar, Guillermo Carroli, Daniel Wojdyla, Edgardo Ábalos, Daniel Giordano, Hassan Ba’aqeel, Ubaldo Farnot, Per Bergsjø, Leiv S. Bakketeig, Pisake Lumbiganon, Liana Campodónico, Yagob Al-Mazrou, Marshall D. Lindheimer, Michael S. Kramer - American Journal of Obstetrics and Gynecology 2006 被引用: 466

  15. Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

    著者: Elaine M. Hylek, Claes Held, John H. Alexander, Renato D. Lópes, Raffaele De Caterina, Daniel Wojdyla, Kurt Huber, Petr Janský, Philippe Gabríel Steg, Michael G. Hanna, Laine Thomas, Lars Wallentin, Christopher B. Granger - Journal of the American College of Cardiology 2014 被引用: 341

  16. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)

    著者: Manuel F. Ugarte‐Gil, Daniel Wojdyla, Guillermo Pons‐Estel, Luís J. Catoggio, Cristina Drenkard, Judith Sarano, Guillermo Berbotto, Eduardo Ferreira Borba, Emília Inoue Sato, João Carlos Tavares Brenol, Óscar Osío Uribe, Luis Alberto Ramírez Gómez, Marlene Guibert-Toledano, Loreto Massardo, Mario H. Cardiel, Luis H. Silveira, R. Chacón, Graciela S. Alarcón, Bernardo A. Pons‐Estel - Annals of the Rheumatic Diseases 2017 被引用: 120

  17. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

    著者: Peter Sinnaeve, Gregory G. Schwartz, Daniel Wojdyla, Marco Alings, Deepak L. Bhatt, Vera Bittner, Chern‐En Chiang, R. Correa, Rafael Díaz, Maria Dorobanţu, Shaun G. Goodman, J. Wouter Jukema, Yong-Un Kim, Robert Pordy, Matthew T. Roe, Rody G. Sy, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Philippe Gabríel Steg, for the ODYSSEY OUTCOMES Investigators - European Heart Journal 2019 被引用: 89

  18. Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study

    著者: José Villar, Guillermo Carroli, Nelly Zavaleta, Allan Donner, Daniel Wojdyla, Aníbal Faúndes, Alejandro Velazco, Vicente Bataglia, Ana Langer, Alberto Cerezo-Narváez, Eliette Valladares, Archana Shah, Liana Campodónico, Mariana Romero, Sofı́a Reynoso, Karla Simônia de Pádua, Daniel Giordano, Marius Kublickas, Arnaldo Acosta - BMJ 2007 被引用: 692

  19. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

    著者: Manuel F. Ugarte‐Gil, Eduardo M. Acevedo‐Vásquez, Graciela S. Alarcón, César Pastor-Asurza, José Alfaro-Lozano, Jorge M. Cucho‐Venegas, María I Segami, Daniel Wojdyla, Enrique R. Soriano, Cristina Drenkard, João Carlos Tavares Brenol, Ana Carolina de Oliveira e Silva Montandon, Lílian Tereza Lavras Costallat, Loreto Massardo, José Fernando Molina-Restrepo, Marlene Guibert-Toledano, Luis H. Silveira, Mary‐Carmen Amigo, Leonor Barile-Fabris, R. Chacón, María H Esteva-Spinetti, Guillermo Pons‐Estel, Gerald McGwin, Bernardo A. Pons‐Estel - Annals of the Rheumatic Diseases 2014 被引用: 126

  20. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

    著者: J. Donald Easton, Renato D. Lópes, M. Cecilia Bahit, Daniel Wojdyla, Christopher B. Granger, Lars Wallentin, Marco Alings, Shinya Goto, Basil S. Lewis, Mårten Rosenqvist, Michael G. Hanna, Puneet Mohan, John H. Alexander, Hans‐Christoph Diener - The Lancet Neurology 2012 被引用: 284

  21. Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

    著者: Steen Husted, Stefan James, Richard C. Becker, Jay Horrow, Hugo Katus, Robert F. Storey, Christopher P. Cannon, Magda Heras, Renato D. Lópes, João Morais, Kenneth W. Mahaffey, Richard G. Bach, Daniel Wojdyla, Lars Wallentin, for the PLATO study group - Circulation Cardiovascular Quality and Outcomes 2012 被引用: 231

  22. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States

    著者: Alexander C. Fanaroff, Pearl Zakroysky, David Dai, Daniel Wojdyla, Matthew W. Sherwood, Matthew T. Roe, Tracy Y. Wang, Eric D. Peterson, Hitinder S. Gurm, Mauricio G. Cohen, John C. Messenger, Sunil V. Rao - Journal of the American College of Cardiology 2017 被引用: 152

  23. Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

    著者: Renato D. Lópes, Sergio Leonardi, Daniel Wojdyla, Amit N. Vora, Laine Thomas, Robert F. Storey, Dragoş Vinereanu, Christopher B. Granger, Shaun G. Goodman, Ronald Aronson, Stephan Windecker, Hölger Thiele, Marco Valgimigli, Roxana Mehran, John H. Alexander - Circulation 2019 被引用: 117

  24. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    著者: Meena P. Rao, Sigrun Halvorsen, Daniel Wojdyla, Laine Thomas, John H. Alexander, Elaine M. Hylek, Michael Hanna, M. Cecilia Bahit, Renato D. Lópes, Raffaele De Caterina, Çetin Erol, Shinya Goto, Fernando Laņas, Basil S. Lewis, Steen Husted, Bernard J. Gersh, Lars Wallentin, Christopher B. Granger - Journal of the American Heart Association 2015 被引用: 97